Anna P Andreou
Anna P Andreou
Primary Investigator, Headache Research, Imperial College London
Verified email at
Cited by
Cited by
Neurobiology of migraine
PJ Goadsby, AR Charbit, AP Andreou, S Akerman, PR Holland
Neuroscience 161 (2), 327-341, 2009
Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping
T Sprenger, CL Seifert, M Valet, AP Andreou, A Foerschler, C Zimmer, ...
Brain 135 (8), 2536-2545, 2012
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine
AP Andreou, PR Holland, S Akerman, O Summ, J Fredrick, PJ Goadsby
Brain 139 (7), 2002-2014, 2016
Acid‐sensing ion channel 1: A novel therapeutic target for migraine with aura
PR Holland, S Akerman, AP Andreou, N Karsan, JA Wemmie, ...
Annals of neurology 72 (4), 559-563, 2012
A prospective real-world analysis of erenumab in refractory chronic migraine
G Lambru, B Hill, M Murphy, I Tylova, AP Andreou
The Journal of Headache and Pain 21 (1), 1-10, 2020
Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics
J Sousa‐Valente, AP Andreou, L Urban, I Nagy
British journal of pharmacology 171 (10), 2508-2527, 2014
Mechanisms of migraine as a chronic evolutive condition
AP Andreou, L Edvinsson
The journal of headache and pain 20 (1), 1-17, 2019
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
O Summ, AR Charbit, AP Andreou, PJ Goadsby
Brain 133 (9), 2540-2548, 2010
Therapeutic potential of novel glutamate receptor antagonists in migraine
AP Andreou, PJ Goadsby
Expert opinion on investigational drugs 18 (6), 789-803, 2009
Evidence for orexinergic mechanisms in migraine
J Hoffmann, W Supronsinchai, S Akerman, AP Andreou, CJ Winrow, ...
Neurobiology of disease 74, 137-143, 2015
Animal models of headache: from bedside to bench and back to bedside
AP Andreou, O Summ, AR Charbit, M Romero-Reyes, PJ Goadsby
Expert review of neurotherapeutics 10 (3), 389-411, 2010
Primary headaches during lifespan
A Straube, A Andreou
The journal of headache and pain 20 (1), 1-14, 2019
Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway
AP Andreou, PJ Goadsby
Cephalalgia 31 (13), 1343-1358, 2011
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
O Summ, AP Andreou, S Akerman, PJ Goadsby
The journal of headache and pain 11 (6), 477-483, 2010
Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel
I Nagy, D Friston, JS Valente, JVT Perez, AP Andreou
Capsaicin as a Therapeutic Molecule, 39-76, 2014
The fifth cranial nerve in headaches
JCA Edvinsson, A Vigaṇ, A Alekseeva, E Alieva, R Arruda, C De Luca, ...
The journal of headache and pain 21 (1), 1-17, 2020
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus
AP Andreou, KG Shields, PJ Goadsby
Neurobiology of disease 37 (2), 314-323, 2010
Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies
YW Woldeamanuel, AP Andreou, RP Cowan
Journal of the neurological sciences 342 (1-2), 1-15, 2014
Emerging drugs for migraine treatment: an update
G Lambru, AP Andreou, M Guglielmetti, P Martelletti
Expert opinion on emerging drugs 23 (4), 301-318, 2018
Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation
AP Andreou, PR Holland, PJ Goadsby
British journal of pharmacology 157 (3), 464-473, 2009
The system can't perform the operation now. Try again later.
Articles 1–20